Pharmacovigilance
Pharmacovigilance is the set of activities aimed at continuously evaluating all information related to the safety of medicinal products, in order to ensure a favorable risk/benefit ratio for the population.
The continuous monitoring of the safety profile of drugs is an integral part of protecting patient health.
At DOC Generici, we choose every day to protect public health by promoting the appropriate and safe use of our medicinal products.
How to Report a Suspected Adverse Reaction
Fill out the specific reporting form available at the following link: www.aifa.gov.it/content/segnalazionireazioni-avverse and send it to the Pharmacovigilance Officer of your local health authority (ASL) via email or fax using the contact details available at: www.aifa.gov.it/responsabilifarmacovigilanza
Access the AIFA website at the link: servizionline.aifa.gov.it/schedasegnalazioni/# and proceed with the online reporting method
Contact the Pharmaceutical Company that holds the Marketing Authorization (AIC) for the medicinal product suspected of causing the adverse reaction.
To report a suspected adverse reaction following the administration of a DOC Generici product, you can use the contacts for the Pharmacovigilance Department listed below: E-mail: farmacovigilanza@genericidoc.it Tel: +39 02 65534273 Fax: +39 02 65534275